CPCP020 Drug Testing Policy Revised Inactive Date - Postponed

BCBSTX has postponed the Jan. 1, 2022 launch of the new lab policies and laboratory program therefore this policy will not be inactivated at this time.

Blue Cross and Blue Shield of TX (BCBSTX) has updated the CPCP020 Drug Testing Clinical Payment and Coding Policy (CPCP). This policy’s inactive date has been extended from November 30, 2021 to December 31, 2021.. For dates of service on or after January 1, 2022, there is no current active version of CPCP020, and it is not to be used for claims adjudication or business purposes.

This CPCP is being replaced by Medical Policy MED209.070. Please see MED209.070 Prescription Medication and Illicit Drug Testing in the Outpatient Setting for dates of service on January 1, 2022, and after. Providers can access the medical policy on our website:

http://www.medicalpolicy.hcsc.net/medicalpolicy/disclaimer?corpEntCd=TX1

Be sure to check eligibility and benefits before rendering service(s) to make sure a procedure is a covered benefit for the member and determine any prior authorization requirements. Refer to Clinical Payment and Coding Policies under Standards and Requirements on the provider website to review the current CPCPs.

If you have any questions or if you need additional information, please contact your BCBSTX Network Management Representative.

Clinical payment and coding policies are based on using healthcare professionals and industry standard guidelines. The clinical payment and coding guidelines are not intended to provide billing or coding advice but to serve as a reference for facilities and providers.